The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms
Authors
Keywords
-
Journal
Lancet Gastroenterology & Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-01
DOI
10.1016/s2468-1253(22)00235-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception
- (2022) Sharia Hernandez et al. CLINICAL CANCER RESEARCH
- Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection
- (2021) Ann Morgell et al. JOURNAL OF PROTEOME RESEARCH
- Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
- (2021) Rita T. Lawlor et al. Cancers
- Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
- (2021) Friederike V. Opitz et al. Cancers
- B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
- (2020) Sadiye Amcaoglu Rieder et al. Cellular & Molecular Immunology
- MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy
- (2020) Shailendra K. Gautam et al. SEMINARS IN IMMUNOLOGY
- Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
- (2020) Yaqing Zhang et al. Cancer Discovery
- Treg Heterogeneity, Function, and Homeostasis
- (2020) Daniil Shevyrev et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
- (2020) Claudio Luchini et al. GUT
- Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer
- (2020) Susanne Roth et al. EBioMedicine
- Immunotherapy for pancreatic cancer: A 2020 update
- (2020) Dimitrios Schizas et al. CANCER TREATMENT REVIEWS
- A Phase 2 Study of Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
- (2020) Annie A. Wu et al. CLINICAL CANCER RESEARCH
- Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms
- (2020) Bo Huang et al. JOURNAL OF PATHOLOGY
- Organoid Models of Tumor Immunology
- (2020) Kanako Yuki et al. TRENDS IN IMMUNOLOGY
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
- (2020) Jennifer S. Davis et al. BMC CANCER
- Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas
- (2020) Francisca Beato et al. LABORATORY INVESTIGATION
- Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma
- (2020) Loryn Holokai et al. Cancers
- HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
- (2019) Chu-Yu Jing et al. Journal for ImmunoTherapy of Cancer
- Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential
- (2019) Ajay V. Maker et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Impact of Immunotherapy after Resection of Pancreatic Cancer
- (2019) Thuy B. Tran et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer
- (2019) Rogier Aäron Gaiser et al. GUT
- Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
- (2019) Eva Karamitopoulou BRITISH JOURNAL OF CANCER
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- Chemoprevention of Colorectal Cancer: Past, Present, and Future
- (2019) Shotaro Umezawa et al. CANCER SCIENCE
- Intraductal Papillary Mucinous Neoplasms Arise from Multiple Independent Clones, Each With Distinct Mutations
- (2019) Catherine G. Fischer et al. GASTROENTEROLOGY
- Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas
- (2019) Raúl N. Mateos et al. Cancer Medicine
- Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
- (2019) Peiwen Ma et al. Frontiers in Immunology
- Development of therapeutic anti-JAGGED1 antibodies for cancer therapy
- (2019) Massimo Masiero et al. MOLECULAR CANCER THERAPEUTICS
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
- (2019) Michael Goggins et al. GUT
- The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression
- (2019) Daniele Vergara et al. Journal of Oncology
- Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
- (2019) Hugo Herrscher et al. CURRENT OPINION IN ONCOLOGY
- Microbiota in pancreatic health and disease: the next frontier in microbiome research
- (2019) Ryan M. Thomas et al. Nature Reviews Gastroenterology & Hepatology
- What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year
- (2018) Rym El Khoury et al. ANNALS OF SURGICAL ONCOLOGY
- Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models
- (2018) Ryan M Thomas et al. CARCINOGENESIS
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- Integrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic/predictive significance
- (2018) Martin Wartenberg et al. CLINICAL CANCER RESEARCH
- Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice
- (2018) Janel L. Kopp et al. GASTROENTEROLOGY
- Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma
- (2018) Masao Tanaka PANCREAS
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer
- (2018) Muhammad Khan et al. MEDICINE
- ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk—Current Status and the Role of IPMN Molecular Biomarkers
- (2018) Ajay V. Maker ANNALS OF SURGICAL ONCOLOGY
- Subtyping of intraductal papillary mucinous neoplasms – pitfalls of MUC 1 immunohistochemistry
- (2018) Pia Klausen et al. APMIS
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
- (2018) Vincent Bernard et al. CLINICAL CANCER RESEARCH
- GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling
- (2018) Noboru Ideno et al. GASTROENTEROLOGY
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
- (2018) Caitlin A. Brennan et al. NATURE REVIEWS MICROBIOLOGY
- Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals
- (2018) Giulia Zerboni et al. PANCREATOLOGY
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival
- (2018) Han Yan et al. CANCER LETTERS
- MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma
- (2017) Shailendra K. Gautam et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study
- (2017) Marie-Luise Kromrey et al. GUT
- Prostaglandin E 2 : A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia
- (2017) Michele T. Yip-Schneider et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas
- (2017) Kiara A. Tulla et al. LANGENBECKS ARCHIVES OF SURGERY
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer
- (2017) A R Rowson-Hodel et al. ONCOGENE
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
- (2017) Jung-Eun Jang et al. Cell Reports
- Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study
- (2017) Yusuke Takasaki et al. United European Gastroenterology Journal
- Myeloid-derived suppressor cells and their role in pancreatic cancer
- (2016) M Pergamo et al. CANCER GENE THERAPY
- Gene-expression profiling to predict responsiveness to immunotherapy
- (2016) N B Jamieson et al. CANCER GENE THERAPY
- Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas
- (2016) Pamela L. Beatty et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas
- (2016) Olca Basturk et al. VIRCHOWS ARCHIV
- Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas
- (2016) Pengpeng Xia et al. Oncotarget
- A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
- (2015) Olca Basturk et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Validation of histomolecular classification utilizing histological subtype, MUC1 and CDX2 for prognostication of resected ampullary adenocarcinoma
- (2015) A Schueneman et al. BRITISH JOURNAL OF CANCER
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Cyst Fluid Biomarkers for Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Critical Review from the International Expert Meeting on Pancreatic Branch-Duct-Intraductal Papillary Mucinous Neoplasms
- (2015) Ajay V. Maker et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- GNAS R201H and Kras G12D cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm
- (2015) K Taki et al. ONCOGENE
- Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
- (2015) Laura Pinton et al. Oncotarget
- HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
- (2015) Murali Janakiram et al. OncoImmunology
- Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas
- (2014) Tetsuya Ikemoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- The Notch ligand Jagged1 as a target for anti-tumor therapy
- (2014) Demin Li Frontiers in Oncology
- HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
- (2013) R. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Indoleamine 2,3-dioxygenase Affects the Aggressiveness of Intraductal Papillary Mucinous Neoplasms Through Foxp3+CD4+CD25+ T Cells in Peripheral Blood
- (2012) Tetsuya Ikemoto et al. PANCREAS
- Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2011) Ajay V. Maker et al. CLINICAL CANCER RESEARCH
- Tumor-infiltrating neutrophils in pancreatic neoplasia
- (2011) Michelle D Reid et al. MODERN PATHOLOGY
- Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2010) Ajay V. Maker et al. ANNALS OF SURGICAL ONCOLOGY
- FOXP3+ Regulatory T Cells and Tumoral Indoleamine 2,3-Dioxygenase Expression Predicts the Carcinogenesis of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2010) Noritoshi Kobayashi et al. PANCREATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search